DRUG Bright Minds Biosciences, Inc.
Biotechnology NasdaqCM
Trading Signals (DRUG)
Overall Signal
SELL
Strong sellish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $20.46
- Medium Support $22.75
- Weak Support $25.04
Resistance Levels
- Weak Resistance $29.62
- Medium Resistance $31.91
- Strong Resistance $34.2
Stop Loss Suggestions
- Conservative $29.16
- Moderate $30.77
- Aggressive $33.06
Analyst Ratings
Current Rating
Last Month
2 Months Ago
3 Months Ago
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | NEUTRAL |
|
Short & Medium Term |
| Oscillators | SELL |
|
Short Term |
| Trend Indicators | BUY |
|
Short & Medium Term |
| Volume Indicators | SELL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (DRUG)
Quarterly Outlook :
2025-07-08
Bullish Scenario
from current 37.01%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (19.31) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (47.59) is in bearish territory, indicating downward momentum. MACD line (-1.03) is below Signal line (0.15) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 5.25, indicating the average weekly price range.
2025-07-08
Base Scenario
from current -11.1%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (19.31) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (47.59) is in bearish territory, indicating downward momentum. MACD line (-1.03) is below Signal line (0.15) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 5.25, indicating the average weekly price range.
2025-07-08
Bearish Scenario
from current -46.26%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (19.31) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (47.59) is in bearish territory, indicating downward momentum. MACD line (-1.03) is below Signal line (0.15) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 5.25, indicating the average weekly price range.
Annual Outlook
2025-07-08
Bullish Scenario
from current 74.02%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (19.31) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (47.59) is in bearish territory, indicating downward momentum. MACD line (-1.03) is below Signal line (0.15) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 5.25, indicating the average weekly price range.
2025-07-08
Base Scenario
from current -22.21%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (19.31) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (47.59) is in bearish territory, indicating downward momentum. MACD line (-1.03) is below Signal line (0.15) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 5.25, indicating the average weekly price range.
2025-07-08
Bearish Scenario
from current -92.53%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (19.31) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (47.59) is in bearish territory, indicating downward momentum. MACD line (-1.03) is below Signal line (0.15) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 5.25, indicating the average weekly price range.
Technical Analysis (DRUG)
Trend Identification
EMA
Exponential Moving Average
Current price (27.33) is between Short MA (27.23) and Long MA (29.58), or near one of them. This suggests consolidation or mixed signals. Short MA (27.23) is below Long MA (29.58), a bearish crossover ('Death Cross' if it's a significant period). This indicates a downward trend. MAs (27.23, 29.58, 32.09) show mixed alignment, suggesting market indecision or range-bound activity. Market is in a choppy or sideways phase. Wait for a clearer trend to emerge before taking directional trades.
MACD
Moving Average Convergence Divergence
MACD line is above the Signal line (bullish crossover). This indicates upward momentum. Histogram (0.2600) is positive and expanding, confirming bullish momentum. Both MACD and Signal lines are below the zero line, reinforcing bearish momentum (bearish territory). A bullish crossover below the zero line can indicate a reversal from a prior downtrend. Consider this as a potential early buy signal.
ADX
Average Directional Index
ADX (13.96) indicates a weak or non-existent trend (ranging market). -DI (18.51) is above +DI (17.00), suggesting a bearish directional bias. Avoid trend-following strategies. Consider range-bound or reversal strategies, or wait for a clearer trend to develop.
Momentum Measurement
RSI (2025-07-08)
Relative Strength Index
RSI (48.59) is in the bearish territory, but not yet oversold. This indicates downward momentum. Monitor for continuation or signs of strength.
OBV (2025-07-08)
On-Balance Volume
OBV (138508827.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic (2025-07-08)
Stochastic Oscillator
Stochastics (%K: 81.46, %D: 76.81) are in the neutral zone (between 20 and 80). A bullish crossover (%K above %D) is observed. This indicates upward momentum. Be cautious if it's already in the overbought region.
CCI (2025-07-08)
Commodity Channel Index
CCI (17.03) is between 0 and +100. This indicates bullish momentum is present, but not yet extreme. A move above 0 from negative territory (bullish zero-line cross) can indicate a potential buy signal.
Volatility Measurement
ATR (2025-07-08)
Average True Range
Current ATR is 1.9800. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2025-07-08)
Volatility Bands
Current price (27.33) is within the Bollinger Bands (24.67 - 29.78). This suggests the price is trading within its typical volatility range. Price is above the Middle Band (27.23), indicating short-term bullish bias. Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility.
Risk Management & Potential Reversals (DRUG)
SAR (2025-07-08)
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 23.51 is 13.98% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
Stochastic (2025-07-08)
Overbought
Stochastic is in overbought territory (81.5). Monitor for potential bearish crossover or movement below 80, which could signal a reversal. Current crossover status: Bullish.
RSI (2025-07-08)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2025-07-08)
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is in the middle of bands with normal bandwidth. No indication of imminent volatility expansion or reversal.
Holder List Top 20 (DRUG)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Janus Henderson Group PLC | INSTITUTIONAL | 1111368 | 15.78% | 2025-03-31 |
| Cormorant Asset Management, LP | INSTITUTIONAL | 1059331 | 15.04% | 2025-03-31 |
| Sio Capital Management, LLC | INSTITUTIONAL | 507562 | 7.21% | 2025-03-31 |
| Commodore Capital Lp | INSTITUTIONAL | 500000 | 7.1% | 2025-03-31 |
| Perceptive Advisors Llc | INSTITUTIONAL | 444649 | 6.31% | 2025-03-31 |
| Vivo Capital, LLC | INSTITUTIONAL | 251572 | 3.57% | 2025-03-31 |
| RA Capital Management, L.P. | INSTITUTIONAL | 206427 | 2.93% | 2025-03-31 |
| Adage Capital Partners GP L.L.C. | INSTITUTIONAL | 200000 | 2.84% | 2025-03-31 |
| Millennium Management Llc | INSTITUTIONAL | 192557 | 2.73% | 2025-03-31 |
| Morgan Stanley | INSTITUTIONAL | 156550 | 2.22% | 2025-03-31 |
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | MUTUALFUND | 14481 | 0.21% | 2025-05-31 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | MUTUALFUND | 3337 | 0.05% | 2025-04-30 |
| iShares Trust-iShares Neuroscience and Healthcare ETF | MUTUALFUND | 550 | 0.01% | 2025-04-30 |
| insidersPercentHeld | MAJOR | 0% | ||
| institutionsPercentHeld | MAJOR | 0% | ||
| institutionsFloatPercentHeld | MAJOR | 0% | ||
| institutionsCount | MAJOR | 0% |